To the best of our knowledge, this is the first study demonstrating the differences in the intensities of monocyte migration marker, CCR1, as well as the impact of selenium in mitigating IL-6 and IL-1β cytokine axes at its molecular level, by comparing the preoperative and postoperative cohorts of CAD patients. The gene discussed is IL1B; the disease is coronary artery disorder.